» Articles » PMID: 28714227

Transepithelial Transport of Milk-derived Angiotensin I-converting Enzyme Inhibitory Peptide with the RLSFNP Sequence

Overview
Date 2017 Jul 18
PMID 28714227
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To exert an antihypertensive effect after oral administration, angiotensin I-converting enzyme (ACE)-inhibitory peptides must remain active after intestinal transport. The purpose of this article is to elucidate the transport permeability and route of ACE-inhibitory peptide Arg-Leu-Ser-Phe-Asn-Pro (RLSFNP) across the intestinal epithelium using Caco-2 cell monolayers.

Results: Intact RLSFNP and RLSFNP breakdown fragments F, FNP, SFNP and RLSF were found in RLSFNP transport solution across Caco-2 cell monolayers using ultra-performance liquid chromatography-tandem mass spectrometry. RLSFNP fragments FNP, SFNP and RLSF also contributed to ACE inhibitory effects. Protease inhibitors (bacitracin and leupeptin) and absorption enhancers (sodium glycocholate hydrate, sodium deoxycholate and Na EDTA) improved the transport flux of RLSFNP. A transport inhibitor experiment showed that intact RLSFNP may be transported via the paracellular route.

Conclusion: Intact RLSFNP can be transported across the Caco-2 cell monolayers via the paracellular route. Extensive hydrolysis was the chief reason for the low permeability of RLSFNP. © 2017 Society of Chemical Industry.

Citing Articles

Intestinal permeability of agaro-oligosaccharides: Transport across Caco-2 cell monolayers and pharmacokinetics in rats.

Shirai I, Karasawa K, Kodaira Y, Iwasaki Y, Shigemura Y, Makabe H Front Nutr. 2022; 9:996607.

PMID: 36185657 PMC: 9525106. DOI: 10.3389/fnut.2022.996607.


Current Evidence on the Bioavailability of Food Bioactive Peptides.

Amigo L, Hernandez-Ledesma B Molecules. 2020; 25(19).

PMID: 33003506 PMC: 7582556. DOI: 10.3390/molecules25194479.


Antihypertensive Effect in Vivo of QAGLSPVR and Its Transepithelial Transport Through the Caco-2 Cell Monolayer.

Sun L, Wu B, Yan M, Hou H, Zhuang Y Mar Drugs. 2019; 17(5).

PMID: 31086041 PMC: 6562704. DOI: 10.3390/md17050288.